BMY(Bristol-Myers Squibb Company) 的财务报表:医疗保健,综合制药。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $46.38B | $46.16B | $45.01B | $48.30B | $48.19B |
| 毛利润 | $36.45B | $36.02B | $34.31B | $34.33B | $34.26B |
| 营业利润 | — | — | — | — | — |
| 净利润 | $6.99B | $6.33B | $8.03B | −$8.95B | $7.05B |
| 经营现金流 | $16.21B | $13.07B | $13.86B | $15.19B | $14.16B |
| 自由现金流 | $15.23B | $11.95B | $12.65B | $13.94B | $12.85B |
| 摊薄每股收益 | $3.12 | $2.95 | $3.86 | $-4.41 | $3.46 |